Not taking the case seems absolutely ridiculous. As others have mentioned, these patent disputes will continue with the makeup of the panel at the CAFC being the concluding factor on who comes out on top. It is not inconceivable that the same thing happens with M-Copax, except MNTA gets a different panel and wins.